[의학신문·일간보사=김정일 기자] Iksu Pharmaceutical (CEO Jeong Yong-jin) last year ‘Yongpyo Woohwangcheongsimwon’Picture>’ Sales exceeded 14 billion won, recording the highest sales of a single brand.
This product also recorded sales of more than 10 billion won in 2018 and 2019.
Iksu Pharmaceutical’s ‘Yongpyo Woohwangcheongsimwon’ consists of a total of 6 types: Yongpyo Woohwangcheongsimwon Pill/Suspension containing natural musk, Yongpyo Wonbang Uhwangcheongsimwon Pill/liquid containing musk substitute (L-muscon), and Yongpyo Uhwangcheongsimwon Pill/liquid. It is an over-the-counter drug that has efficacy and effects such as palpitations, mental anxiety, high blood pressure, and stroke.
An official from Iksu Pharmaceutical said, “We are concentrating our capabilities to continuously supply products despite difficulties such as rising international trade prices and shortages of musk and oxbow, the main raw materials of Woohwangchongshimwon due to the Russia-Ukraine crisis.” “We are supplying products to pharmacies nationwide through ‘Iksu Mall’, an online shopping mall for Iksu Pharmaceutical.”
The official said, “We plan to continue to grow the ‘Yongpyo Woohwangcheongsimwon’ brand through continuous marketing and product management.”
